Page URL:

NHS will become flagship health service for genomic medicine

9 July 2018
Appeared in BioNews 957

Genomics England and the NHS will incorporate genome sequencing into routine care by establishing the Genomic Medicine Service.

The service, to launch in October, will allow the NHS to use DNA testing more widely in patient diagnoses and treatments. Hospitals will be connected to specialist centres that can test patients' cancer genomes or diagnose rare diseases and find the most effective treatments, including reducing adverse drug reactions. This is intended to allow patients to access the best treatments for their needs more quickly.

'Genomics England's mission is to realise the enormous potential of genomic information to enable precision medicine,' said Professor John Mattick, Genomics England's chief executive. 'As the technology and our understanding continue to grow over the coming years, we will provide genome analyses to inform personalised treatments and preventative actions tailored to individual circumstances.'

Genomics England has now passed the 70,000 mark in its project to sequence 100,000 genomes, just in time for the NHS's 70th birthday. The focus of the project has been on patients with cancer or rare diseases. The NHS Genomic Medicine Service will make use of this data to tailor patient treatment.

Professor Dame Sue Hill, Chief Scientific Officer for England and lead for the NHS Genomics programme, said: 'The NHS has harnessed cutting-edge science and technology through the project to deliver real benefits for patients with rare diseases and cancer and in the growing field of genomics and health we are, once more, building a world-leading service that is admired and respected across the globe.'

The Genomic Medicine Service will start with treatments that have proven benefits for cancers and rare diseases. A future goal is to detect patients with early onset neurological diseases, including dementia, multiple sclerosis and Parkinson's disease. There is research ongoing into how DNA tests can work with other health and lifestyle information to pinpoint patients with risks for hypertension, diabetes and cancer.

'Genetic sequencing can revolutionise healthcare by offering truly personalised care to patients and their families,' said James O'Shaughnessy, parliamentary under-secretary of state for health in the House of Lords. 'This project is a shining example of a partnership between the public sector, the life sciences industry and the research community – with NHS patients reaping the benefits.'

Professor Dame Sue Hill will be discussing the future of NHS genomic medicine at the free-to-attend Progress Educational Trust/Genomics England event 'How Do We Make Genomics Everybody's Business?', in Manchester on the evening of Wednesday 5 September 2018.

See here for further details, and email to book your free place.

As the NHS celebrates 70 years Genomics England sequences its 70,000th genome
Genomics England |  4 July 2018
NHS future: Why genome mapping could be good news
BBC News |  3 July 2018
Routine DNA tests will put NHS at the 'forefront of medicine'
The Guardian |  3 July 2018
The 100‚ÄČ000 Genomes Project: bringing whole genome sequencing to the NHS
British Medical Journal |  24 April 2018
What will follow the first hundred thousand genomes in the NHS?
Personalised Medicine |  20 June 2018
15 July 2019 - by Charlotte Spicer 
The first RNA-based therapy has been approved for NHS use in England...
4 February 2019 - by Julianna Photopoulos 
The UK's health secretary Matt Hancock has announced that the NHS is considering offering healthy people the opportunity to pay to have their genomes sequenced...
14 January 2019 - by Grace O'Regan 
The Long Term Plan announced by the NHS this week has detailed a proposal to offer whole-genome sequencing for all children with cancer in England...
19 November 2018 - by BioNews 
This film documents the Progress Educational Trust/Genomics England event 'How Do We Make Genomics Everybody's Business?', which formed part of the Genomics Conversation...
8 October 2018 - by Dr Rosie Morley 
Plans to sequence five million genomes in the next five years were announced by the Secretary of State for Health and Social Care, Matt Hancock last week.
25 June 2018 - by Pod Academy 
Hear genomics and industrial strategy discussed by Sarah Norcross (Progress Educational Trust), Dr Eliot Forster (MedCity), Dr Athena Matakidou (AstraZeneca), Dr Edward Hockings (Ethics and Genetics) and Dr Jayne Spink (Genetic Alliance UK)...
23 April 2018 - by Rikita Patel 
The uptake of genomic medicine could be hampered by funding gaps in the NHS, according to a report by the House of Commons Science and Technology Committee...
to add a Comment.

By posting a comment you agree to abide by the BioNews terms and conditions

Syndicate this story - click here to enquire about using this story.